Janus Biotherapeutics, Inc.
Records under this name other than the patents Janus Biotherapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 2 of 2 · Back to Janus Biotherapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,873,694 | Imidazole quinoline-based immune system modulators Lapsed on the fee record Ended Jan 23, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 23, 2026 | USPTO record |
| US 9,637,489 | Immune system modulators Lapsed on the fee record Ended May 2, 2025 · USPTO record | Lapsed on the fee record | Ended May 2, 2025 | USPTO record |